Correlation Between Acumen Pharmaceuticals and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Citius Oncology,, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Citius Oncology,.
Diversification Opportunities for Acumen Pharmaceuticals and Citius Oncology,
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Acumen and Citius is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Citius Oncology, go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Citius Oncology,
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Citius Oncology,. But the stock apears to be less risky and, when comparing its historical volatility, Acumen Pharmaceuticals is 2.04 times less risky than Citius Oncology,. The stock trades about -0.01 of its potential returns per unit of risk. The Citius Oncology, is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 105.00 in Citius Oncology, on September 12, 2024 and sell it today you would earn a total of 5.00 from holding Citius Oncology, or generate 4.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Citius Oncology,
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Citius Oncology, |
Acumen Pharmaceuticals and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Citius Oncology,
The main advantage of trading using opposite Acumen Pharmaceuticals and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Acumen Pharmaceuticals vs. Equillium | Acumen Pharmaceuticals vs. DiaMedica Therapeutics | Acumen Pharmaceuticals vs. Valneva SE ADR | Acumen Pharmaceuticals vs. Vivani Medical |
| Citius Oncology, vs. Evoke Pharma | Citius Oncology, vs. Dynavax Technologies | Citius Oncology, vs. Amphastar P | Citius Oncology, vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |